Groupon Inc. (GRPN) is Trading Higher on Unusual Volume for February 12

Equities Staff |

Groupon Inc. (GRPN) experienced unusually high volume on Feb. 12, as the stock gained 29.69% to a closing price of $2.91. The stock saw 27.04 million shares trade hands over the course of the day on 47,001 trades. Given that the stock’s average daily volume over the last month has been 9.15 million shares a day, this represents a pretty substantial spike over the norm.

Groupon Inc. has a P/B ratio of 2.96. It also has a P/E ratio of 20.4. The stock has traded between $8.37 and $2.15 over the last 52-weeks, its 50-day SMA is now $2.82, and its 200-day SMA $4.17.

Groupon Inc provides a local e-commerce marketplace that connects merchants to consumers by offering goods and services at discount. The Company features a daily deal on stuff to do, see, eat, and buy.

Headquartered in Chicago, IL, Groupon Inc. has 11,843 employees and is currently under the leadership of CEO Rich Williams.

For a complete fundamental analysis analysis of Groupon Inc., check out’s Stock Valuation Analysis report for GRPN. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…